Table 2.
Pathologic characteristics.
| Variable | Value | |
|---|---|---|
| Tumor Characteristics | ||
| Tumoral size N (%) | <2 cm | 19 (17,12) |
| >2 cm | 92 (82,88) | |
| Resectability criteria N (%) | Resectable disease | 94,6 (105) |
| Borderline disease | 5,4 (6) | |
| Type of tumor N (%) | Ductal adenocarcinoma | 67 (60,36) |
| Ampullary tumors | 25 (22,5) | |
| Cystadenocarcinoma | 5 (4,50) | |
| Other | 14 (12,64) | |
| Differentiation grade N (%) | Well differentiated | 35 (31,53) |
| Moderate grade | 64 (57,66) | |
| Poorly differentiated | 10 (9,01) | |
| Undifferentiated | 2 (1,80) | |
| Adjuvant therapy N (%) | Received | 64 (57,66) |
| Pathology report | ||
| Vascular invasion N (%) | 67 (60,36) | |
| Perineural invasion N (%) | 76 (68,47) | |
| R0 margins N (%) | 106 (95,05) | |
| Positive rate of HLA node N (%) | 24 (21,62) | |
| Tumoral relapse at 5 years % | 55,8 | |